NR3C2 rs1047776: What Your Genotype Means
The rs1047776 single nucleotide polymorphism is an exon variant in the NR3C2 gene, which encodes the human mineralocorticoid receptor. It causes an isoleucine-to-valine amino acid substitution (Ile180Val) that slightly alters the receptor's transcriptional activity. Research associates this variant with subtle differences in autonomic reactivity and cortisol feedback regulation during acute psychological or cognitive stress.
What each genotype means
Typical mineralocorticoid receptor activity
You carry two copies of the common A allele, which encodes the baseline isoleucine residue at position 180 (Ile180) of the mineralocorticoid receptor. In observational studies, this genotype reflects standard receptor transactivation and typical autonomic and neuroendocrine stress reactivity under acute cognitive challenges. Evidence linking this common variant to long-term health outcomes remains limited and non-diagnostic.
Carried by approximately 75% to 80% of individuals of European ancestry and is the predominant genotype across global populations.
Altered stress response reactivity
You carry one copy of the G allele, resulting in a single amino acid substitution (Ile180Val) in the mineralocorticoid receptor. Research suggests this change may modestly modulate receptor transactivation and influence autonomic reactivity during acute psychological or cognitive stress, though findings across diverse populations remain limited and mixed. This variant does not predict or diagnose any specific stress-related condition on its own.
Carried by approximately 18% to 24% of individuals of European ancestry, with significantly lower frequencies observed in East Asian and African populations.
Altered stress response reactivity
You carry two copies of the less common G allele, encoding valine at position 180 (Val180Val) of the mineralocorticoid receptor. Preliminary studies indicate this genotype may alter receptor transactivation capacity and contribute to differences in autonomic nervous system balance under stress compared to the typical AA genotype. Because existing scientific evidence is limited and exploratory, this genotype is not diagnostic of any medical or psychiatric condition.
Carried by approximately 1% to 2% of individuals of European ancestry and is extremely rare or absent in East Asian populations.
Variant Architecture and Molecular Impact
The single nucleotide polymorphism rs1047776 is located within exon 2 of the NR3C2 gene on chromosome 4. It represents an A-to-G transition that translates to a missense substitution of isoleucine for valine at amino acid position 180 (commonly designated as Ile180Val or I180V). The NR3C2 gene encodes the mineralocorticoid receptor, a nuclear receptor family protein that functions as a ligand-dependent transcription factor. Functional laboratory studies indicate that the valine substitution subtly modulates the transactivation capacity of the receptor when bound to its endogenous steroid ligands, particularly aldosterone and cortisol. Because the amino acid substitution resides in the N-terminal transactivation domain, it does not abolish hormone binding, but instead influences how effectively the receptor recruits coregulatory molecules to modulate target gene transcription.
Biological Role of the NR3C2 Receptor
While traditionally recognized for regulating fluid homeostasis and sodium retention in renal epithelial tissues in response to aldosterone, the mineralocorticoid receptor also plays a crucial regulatory role in the central nervous system. In the brain, especially within the hippocampus and prefrontal cortex, mineralocorticoid receptors have a high affinity for cortisol and are occupied under basal, resting conditions. They act in concert with lower-affinity glucocorticoid receptors to maintain baseline tone of the hypothalamic-pituitary-adrenal (HPA) axis and coordinate rapid feedback during stress. Through these neural pathways, mineralocorticoid receptors help calibrate autonomic nervous system reactivity, appraisal of novel environmental challenges, and the subsequent recovery phase following acute mental or physiological demands.
Current Scientific Evidence and Limitations
A modest body of psychoneuroendocrinology research has examined how the rs1047776 variant influences human physiological reactions to acute stressors, such as standardized laboratory cognitive challenges and public-speaking tasks. Certain candidate-gene studies have observed that carriers of the minor G allele (encoding Val180) exhibit altered autonomic responses—such as variations in heart rate recovery, blood pressure reactivity, or cortisol output—compared to individuals homozygous for the ancestral A allele. However, the overall strength of this scientific evidence is categorized as limited. Many published associations originate from small observational cohorts, and broader genome-wide association studies (GWAS) have not established definitive, large-effect links to psychiatric diagnoses or cardiovascular disease. Consequently, findings reflect nuanced statistical differences in healthy stress physiology rather than clinical pathology.
Population Distribution and Ancestry
The minor G allele for rs1047776 is present at polymorphic frequencies across several world populations, though its distribution exhibits ancestral variation. Large reference collections, such as the Genome Aggregation Database (gnomAD), show that the minor G allele frequency typically ranges between 0.10 and 0.14 among individuals of European ancestry. In contrast, the variant is observed at substantially lower frequencies or is comparatively rare in several East Asian and African ancestral groups. Because the vast majority of experimental stress reactivity studies have been conducted within predominantly European cohorts, the extent to which these findings apply across diverse global backgrounds remains uncharacterized and requires careful interpretation.
What Readers Should and Should Not Do
Discovering your rs1047776 genotype provides an educational glimpse into how common genetic variability can fine-tune normal physiological mechanisms like stress signaling. It is essential to recognize that this variant is neither diagnostic nor predictive of any medical condition, such as hypertension, anxiety disorders, or adrenal insufficiency. Stress reactivity is a highly complex, polygenic trait heavily shaped by lifestyle, environment, early-life experience, and overall psychological resilience. Readers should never alter prescribed therapies, such as mineralocorticoid antagonists or corticosteroid medications, based on genetic results. Any concerns regarding blood pressure, stress management, or medication dosing should always be addressed directly with a physician or clinical pharmacist.
How common is this variant?
According to gnomAD data, the minor G allele occurs at an estimated frequency of 10% to 14% across populations of European descent, while remaining less frequent in East Asian and African ancestries.
Frequently asked questions
Does having the rs1047776 G allele mean I have high anxiety?
No. The rs1047776 variant is not a diagnostic marker for anxiety, depression, or any clinical disorder. Scientific studies only suggest subtle differences in autonomic and cortisol responses during short-term laboratory stress challenges.
What is the difference between an isoleucine and a valine at position 180?
The rs1047776 variant causes a single amino acid swap from isoleucine (A allele) to valine (G allele) in the N-terminal region of the mineralocorticoid receptor. In vitro studies demonstrate that this subtle alteration can slightly modulate how the receptor regulates gene expression when activated by stress hormones.
Can this genetic test determine my cortisol levels?
No, a genetic variant cannot measure your circulating hormone levels. Cortisol output fluctuates significantly throughout the day according to your circadian rhythm, sleep quality, acute stress, and physical health, all of which exert much stronger influences than a single genetic marker.
Should I change my medications if I carry the rs1047776 variant?
No. There are no clinical guidelines recommending medication changes or dosage adjustments based on rs1047776. Never modify blood pressure treatments, steroid therapies, or any prescribed medications without consulting your prescribing healthcare provider or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1047776?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29